| Filed On | Filing |
|---|---|
| 21 Oct 2026 |
Form 4: ADAR1 Capital Management, Llc, 10% owner and 1 other
Bought 336,528 shares ($507K) · Bought 254,342 shares ($406K) · Bought 331,979 shares ($551K) |
| 15 Oct 2026 | SCHEDULE 13G/A |
| 13 Oct 2026 | SCHEDULE 13G/A |
| 09 Oct 2026 | SCHEDULE 13G/A |
| 08 Oct 2026 |
8-K: Other Events
Forward-Looking Statements Disclaimers Except for historical information, all of the statements, expectations and assumptions contained in this presentation are forward-looking statements. These forward-looking statements include, but ar... |
| 17 Sep 2026 |
Form 4: Doogan Declan, Director
Bought 53,000 shares ($102K) |
| 15 Sep 2026 |
Form 4: Giordano Christopher Thomas, Director
Bought 6,000 shares ($11.3K) · Bought 4,850 shares ($8.84K) |
| 15 Sep 2026 |
Form 4: Staab Thomas R Ii, Chief Financial Officer
Bought 5,675 shares ($11K) |
| 11 Sep 2026 | SCHEDULE 13G/A |
| 09 Sep 2026 |
8-K: Regulation FD Disclosure
LEVEL Clinical Trial Results September 09, 2026 Exhibit 99.1 |
| 08 Sep 2026 |
Form 4: ADAR1 Capital Management, Llc, 10% owner and 1 other
Bought 900,000 shares ($1.6M) |
| 08 Sep 2026 | SCHEDULE 13G |
| 08 Sep 2026 | SCHEDULE 13G/A |
| 02 Sep 2026 |
Form 4: ADAR1 Capital Management, Llc, 10% owner and 1 other
Bought 403,571 shares ($723K) · Bought 179,058 shares ($322K) · Bought 187,704 shares ($338K) |
| 27 Aug 2026 | SCHEDULE 13G |
| 27 Aug 2026 | SCHEDULE 13G |
| 24 Aug 2026 |
Form 4: ADAR1 Capital Management, Llc, 10% owner and 1 other
Bought 202,124 shares ($360K) · Bought 716,369 shares ($1.27M) · Bought 107,374 shares ($188K) |
| 24 Aug 2026 |
Form 3: ADAR1 Capital Management, Llc, 10% owner and 1 other
Holds 3,827,951 shares of Common Stock |
| 18 Aug 2026 | SCHEDULE 13G |
| 14 Aug 2026 | SCHEDULE 13G/A |
Loading...